Life Scientist > Life Sciences

New antibiotic sourced from 'microbial dark matter'

25 August, 2023

A powerful new antibiotic, isolated from bacteria that could not be studied before, seems capable of combating harmful bacteria and even multi-resistant 'superbugs'.


Simple fragrance release boosts memory in elders

24 August, 2023

Neuroscientists at the University of California, Irvine (UCI) have found that releasing aromas into the bedrooms of sleeping elders helps to increase cognitive capacity.


Hookworms could offer protection from severe COVID

21 August, 2023

Mice infected with hookworm were less likely to develop severe COVID symptoms and recovered from the infection much more quickly than their counterparts.


RNA therapy activates dendritic cells to combat melanoma

15 August, 2023

The RNA-based strategy activated dendritic cells that eradicated tumours and prevented their recurrence in mouse models of melanoma.


Vaccine candidate offers hope against EBV-associated diseases

11 August, 2023

The new vaccine candidate offers a breakthrough approach that combines two powerful arms of the immune system to target Epstein–Barr virus in both acute and latent infection.


Probiotics could slow age-related cognitive decline

08 August, 2023

US researchers have suggested that taking a probiotic could help prevent the decline in memory and thinking that can accompany aging.


Novel vaccine may reduce the impact of Alzheimer's disease

02 August, 2023

A novel vaccine that targets inflamed brain cells associated with Alzheimer's disease may hold the key to potentially preventing or modifying the course of the disease.


Breastfeeding mums' diet may affect children's asthma risk

01 August, 2023

A high-fibre diet in mothers helps to reduce the risk of infants developing severe lower respiratory infections, which can predispose the infant to chronic lung diseases.


Strep A primarily transmitted through bacteria in throat

31 July, 2023

Group A Streptococcus infections are more likely transmitted from asymptomatic throat carriage than skin-to-skin contact in communities with high rates of infection.


Powerful mRNA vaccine to tackle malaria

24 July, 2023

The mRNA-based vaccine can effectively target and stimulate protective immune cell responses against the malaria-causing parasite Plasmodium in preclinical models.


Genetic basis found for asymptomatic COVID-19 infection

21 July, 2023

A person who carries one copy of the HLA-B15 gene is twice as likely to remain asymptomatic, while someone with two copies of the gene is eight times more likely to show no symptoms.


Evolution of artificial cells shows that life finds a way

14 July, 2023

A synthetically constructed cell was found to evolve just as fast as a normal cell, despite having a significant handicap.


Residual antibiotics found in cooked food

12 July, 2023

Hong Kong researchers have been examining the use of antibiotics and their impact in the context of local environmental ecology, food safety and children's health.


Nutrient 'tug of war' determines anticancer activity

11 July, 2023

Immune and tumour cells compete over glutamine, a major nutrient in their local environment, with significant implications for anticancer activity.


Chikungunya vaccine provokes immune response in phase 3 trial

05 July, 2023

A vaccine candidate for chikungunya disease has been found to produce an immune response in 99% of phase 3 trial participants.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd